Using a mixed methods research design to investigate complementary alternative medicine (CAM) use among women with breast cancer in Ireland

被引:31
作者
Fox, Patricia [1 ]
Butler, Michelle [1 ]
Coughlan, Barbara [1 ]
Murray, Mary [2 ]
Boland, Noreen [3 ]
Hanan, Terry [4 ]
Murphy, Hilary [4 ]
Forrester, Pauline [4 ]
O' Brien, Marie [2 ]
O' Sullivan, Nollaig [4 ]
机构
[1] Univ Coll Dublin, UCD Sch Nursing Midwifery & Hlth Syst, Dublin 2, Ireland
[2] St Vincents Univ Hosp, Dublin, Ireland
[3] St James Hosp, Dublin, Ireland
[4] Adelaide Meath & Natl Childrens Hosp, Dublin, Ireland
关键词
Mixed methods; Breast cancer; Complementary alternative medicine; Ireland; Complementary therapies; CHINESE WOMEN; THERAPY USE; PREVALENCE; SURVIVORS; DECISION;
D O I
10.1016/j.ejon.2012.10.008
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate complementary and alternative medicine (CAM) use among women with breast cancer in Ireland using a mixed methods modified sequential explanatory design. Methods: Semi-structured interviews were conducted with oncology professionals (n = 20) and CAM practitioners (n = 20) and this was followed by a survey of 406 women with breast cancer using the 'Use of Complementary and Alternative Therapies Survey' questionnaire (UCATS) (Lengacher et al., 2003). Follow up interviews were subsequently undertaken with a subset of this survey sample (n = 31). Results: Over half of those surveyed (55.7%, n = 226) used some form of CAM since diagnosis. The most frequently used therapies were massage, herbal supplements (including herbs with oestrogenic properties), antioxidants, relaxation, counselling, health supplements, reflexology, reiki and support groups. Dietary interventions were used primarily to reduce symptoms and/or side effects while reduction of psychological stress was the primary reason for use of stress-reducing therapies. Most respondents reported that the CAM therapies they had used were helpful. The qualitative data elaborated on and provided clarification of the survey results. Conclusions: Similar to international studies, CAM is popular among women with breast cancer in Ireland. As such, the challenge for Irish oncology professionals is to identify low risk CAM therapies that are likely to benefit patients while educating patients and themselves on therapies which may be of concern. This study clearly illustrates the benefits of using a mixed methods approach to enhance our understanding of a complex clinical issue and thus we recommend that this method should be the method of choice when planning health services research. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:490 / 497
页数:8
相关论文
共 54 条
[21]   Integrated care: Utilisation of complementary and alternative medicine within a conventional cancer treatment centre [J].
Gage, Heather ;
Storey, Lesley ;
McDowell, Charlotte ;
Maguire, Gail ;
Williams, Peter ;
Faithfull, Sara ;
Thomas, Hilary ;
Poole, Karen .
COMPLEMENTARY THERAPIES IN MEDICINE, 2009, 17 (02) :84-91
[22]  
Gray R E, 1999, Cancer Prev Control, V3, P77
[23]  
Greene J., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [DOI 10.3102/01623737011003255, 10.3102/01623737011003255]
[24]  
Greene JC., 2007, MIXED METHODS SOCIAL
[25]   Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study [J].
Greenlee, Heather ;
Kwan, Marilyn L. ;
Ergas, Isaac Joshua ;
Sherman, Karen J. ;
Krathwohl, Sarah E. ;
Bonnell, Christine ;
Lee, Marion M. ;
Kushi, Lawrence H. .
BREAST CANCER RESEARCH AND TREATMENT, 2009, 117 (03) :653-665
[26]  
Hammersley M., 2008, Advances in mixed methods research, P22
[27]  
Hann Danette, 2005, Integr Cancer Ther, V4, P14, DOI 10.1177/1534735404273723
[28]   Complementary and alternative medicine use by patients with cancer in Wales: a cross sectional survey [J].
Harris, P ;
Finlay, IG ;
Cook, A ;
Thomas, KJ ;
Hood, K .
COMPLEMENTARY THERAPIES IN MEDICINE, 2003, 11 (04) :249-253
[29]   The use of complementary and alternative medicines among patients with locally advanced breast cancer - A descriptive study [J].
Helyer L.K. ;
Chin S. ;
Chui B.K. ;
Fitzgerald B. ;
Verma S. ;
Rakovitch E. ;
Dranitsaris G. ;
Clemons M. .
BMC Cancer, 6 (1)
[30]  
Henderson JW, 2004, ALTERN THER HEALTH M, V10, P52